ScreenPoint Medical

ScreenPoint Medical

Gepubliceerd op: 18 mei 2022

ScreenPoint Medical develops and markets AI solutions for the early detection of breast cancer. With offices in the Netherlands and the United States, it operates globally, with customers in over 30 countries.

Activiteiten op AI gebied

We develop software which is based on deep learning. This is the core of our detection product.

Bijdrage aan NL AIC

Through active participation

Waarom NL AIC?

Our objective is to share knowledge and experience and learn from others. Also, we believe infrastructural improvements are necessary in the Netherlands. These are best achieved collectively.

Bekijk de website van de deelnemer